Viewing Study NCT07169903


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2025-12-25 @ 5:11 PM
Study NCT ID: NCT07169903
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-12
First Post: 2025-06-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module